New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Saturday, Nov 21, 2026
Export PBM’s income statement to Excel — free account
Psyence Biomedical Ltd.
PBM
2.97
0.11
+3.85%
After hours trading: 3.01, up 1.35%, last trade Fri 4:09pm Eastern.
Follow PBM
Alert me
Psyence Biomedical Ltd. (PBM) P/E ratio
As of Nov 20, 2026, Psyence Biomedical Ltd. (PBM) trades at a P/E ratio of 0.1×. Over the past ten years it has ranged from 0.0× (September 2024) to 2,929,688× (September 2023); the current reading is higher than 25% of that period. That is below the Biotechnology industry median of 8.5× and below the Healthcare sector median of 21.7×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|
Against its own ten years
Low 0.0×
High 2,929,688×
Ten-year median
1.1×
Current reading's percentile
6
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| JSPR Jasper Therapeutics, Inc. compare | n/m |
| PASG Passage Bio, Inc. compare | n/m |
| BCDA BioCardia, Inc. compare | n/m |
| LSTA Lisata Therapeutics, Inc. compare | n/m |
| AEON AEON Biopharma, Inc. compare | n/m |
| HIND Vyome Holdings, Inc. compare | n/m |
| BIVI BioVie Inc. compare | n/m |
| PBM Psyence Biomedical Ltd. | 0.1× |
| RADX Radiopharm Theranostics Limited - Sponsored ADR compare | — |
| Biotechnology industry median | 8.5× |
| Healthcare sector median | 21.7× |
| Market median | 16.6× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)